IT8547600A0 - Li contengono composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmacuetiche che - Google Patents

Li contengono composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmacuetiche che

Info

Publication number
IT8547600A0
IT8547600A0 IT8547600A IT4760085A IT8547600A0 IT 8547600 A0 IT8547600 A0 IT 8547600A0 IT 8547600 A IT8547600 A IT 8547600A IT 4760085 A IT4760085 A IT 4760085A IT 8547600 A0 IT8547600 A0 IT 8547600A0
Authority
IT
Italy
Prior art keywords
tetrahydrocarbozolon
pharmacuetic
procedures
compositions
preparing
Prior art date
Application number
IT8547600A
Other languages
English (en)
Other versions
IT1182150B (it
Inventor
Jan Harold Coates
James Angus Bell
David Cedric Humber
Ewan George Blanch
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848401888A external-priority patent/GB8401888D0/en
Priority claimed from GB848425959A external-priority patent/GB8425959D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT8547600A0 publication Critical patent/IT8547600A0/it
Application granted granted Critical
Publication of IT1182150B publication Critical patent/IT1182150B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT47600/85A 1984-01-25 1985-01-25 Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono IT1182150B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848401888A GB8401888D0 (en) 1984-01-25 1984-01-25 Heterocyclic compounds
GB848425959A GB8425959D0 (en) 1984-10-15 1984-10-15 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
IT8547600A0 true IT8547600A0 (it) 1985-01-25
IT1182150B IT1182150B (it) 1987-09-30

Family

ID=26287221

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47600/85A IT1182150B (it) 1984-01-25 1985-01-25 Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono

Country Status (29)

Country Link
KR (1) KR920003064B1 (it)
AT (1) AT392276B (it)
AU (1) AU579132B2 (it)
BE (1) BE901576A (it)
CA (1) CA1252793A (it)
CH (1) CH664152A5 (it)
CY (1) CY1479A (it)
CZ (1) CZ404391A3 (it)
DE (2) DE19375046I2 (it)
DK (1) DK169521B1 (it)
ES (3) ES8609309A1 (it)
FI (1) FI84349C (it)
FR (1) FR2561244B1 (it)
GB (1) GB2153821B (it)
GR (1) GR850219B (it)
HK (1) HK33189A (it)
HU (1) HU193592B (it)
IE (1) IE57809B1 (it)
IL (1) IL74165A (it)
IT (1) IT1182150B (it)
LU (2) LU85743A1 (it)
NL (2) NL190373C (it)
NO (2) NO164025C (it)
NZ (1) NZ210940A (it)
PH (1) PH22672A (it)
PT (1) PT79890B (it)
SE (1) SE460359B (it)
SG (1) SG7089G (it)
SK (1) SK404391A3 (it)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
EP0385517B1 (en) * 1985-03-14 1993-04-14 BEECHAM GROUP plc Medicaments for the treatment of emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8518658D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Medicaments
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
US5204356A (en) * 1985-07-24 1993-04-20 Glaxo Group Limited Treatment of anxiety
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518745D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
AT396870B (de) * 1986-08-07 1993-12-27 Sandoz Ag Verfahren zur herstellung einer galenischen formulierung zur nasalen verabreichung von serotoninantagonisten
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
EP0279114B2 (en) * 1986-11-21 1995-08-23 Glaxo Group Limited Medicaments for the treatment or prevention of the withdrawal syndrome
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
US5202343A (en) * 1986-11-28 1993-04-13 Glaxo Group Limited Tricyclic ketones useful as HT3 -receptor antagonists
GB8812002D0 (en) * 1988-05-20 1988-06-22 Glaxo Group Ltd Chemical compounds
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
ES2052585T3 (es) * 1986-12-17 1994-07-16 Glaxo Group Ltd Uso de derivados cetonicos en el tratamiento de desordenes cognitivos.
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
EP0278173B1 (en) * 1986-12-17 1993-11-03 Glaxo Group Limited Use of heterocyclic derivatives in the treatment of depressions
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
EP0291172B1 (en) * 1987-04-14 1992-11-19 Glaxo Group Limited Ketone derivatives
GB2205745B (en) * 1987-06-16 1990-09-19 Nat Res Dev Use of dioxopiperidine derivatives as analgesics
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8723157D0 (en) * 1987-10-02 1987-11-04 Beecham Group Plc Compounds
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
US4939144A (en) * 1987-10-22 1990-07-03 Glaxo Group Limited Tricyclic ketone derivatives as 5-HT antagonists
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
JPH0249772A (ja) * 1988-04-07 1990-02-20 Glaxo Group Ltd イミダゾール誘導体
DK185489A (da) * 1988-04-22 1989-10-23 Duphar Int Res Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
JPH0256485A (ja) * 1988-04-27 1990-02-26 Glaxo Group Ltd ラクタム誘導体
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
US5290785A (en) * 1988-09-27 1994-03-01 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for ischemic diseases
US5173493A (en) * 1988-09-27 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Pyridoindole derivatives and processes for preparation thereof
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
FR2639944B1 (fr) * 1988-12-06 1991-01-18 Adir Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2004911A1 (en) * 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
EP0392663A1 (en) * 1989-03-13 1990-10-17 Ono Pharmaceutical Co., Ltd. Carboline derivative as a 5-HT3 receptor antagonist
EP0422154B1 (en) * 1989-04-21 1993-12-01 Sandoz Erfindungen Verwaltungsgesellschaft M.B.H. Therapeutic use of 5-ht3 receptor antagonists
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
GB8917557D0 (en) * 1989-08-01 1989-09-13 Glaxo Group Ltd Medicaments
US5276050A (en) * 1989-08-01 1994-01-04 Glaxo Group Limited Medicaments
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
AU2295792A (en) * 1991-06-26 1993-01-25 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
ES2043535B1 (es) * 1992-03-13 1994-08-01 Vita Invest Sa Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
HU212934B (en) 1992-10-14 1996-12-30 Richter Gedeon Vegyeszet Process for producing novel alkoxalylated carbazolone derivatives
JPH08507514A (ja) * 1993-03-08 1996-08-13 藤沢薬品工業株式会社 脳血管性疾患を治療または予防するための薬物
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB2327348A (en) * 1994-06-28 1999-01-27 Kenneth Francis Prendergast Pharmaceutical use of ondansetron
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US5969137A (en) * 1996-09-19 1999-10-19 Virginia Commonwealth University Benzylamidine derivatives with serotonin receptor binding activity
JP2002538102A (ja) 1999-03-01 2002-11-12 セプラコア インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
RU2207340C2 (ru) * 2001-08-10 2003-06-27 Ципла Лтд. Способ получения 1,2,3,9-тетрагидро-9-метил-3-[(2-метил-1н-имидазол-1-ил)метил]-4н-карбазол -4-она или его фармацевтически приемлемых солей
CN1665823A (zh) 2002-04-29 2005-09-07 特瓦药厂有限公司 制备1,2,3,9－四氢－9－甲基－3－[(2－甲基－1h－咪唑－1－基)甲基]－4h－咔唑－4－酮的方法
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
GB2398071B (en) * 2003-01-24 2006-06-07 Synthon Bv Process for making ondansetron and intermediate thereof
ES2238001B1 (es) * 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
WO2005108392A2 (en) 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
WO2007004041A2 (en) * 2005-07-05 2007-01-11 Orchid Research Laboratories Limited New compounds and their pharmaceutical use
JP5955767B2 (ja) 2009-05-20 2016-07-20 インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） 損傷性前庭障害の処置における使用のためのセロトニン５−ｈｔ３受容体拮抗薬
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
CN115611864A (zh) * 2022-11-01 2023-01-17 常州兰陵制药有限公司 一种昂丹司琼类化合物及其制备方法与应用
GB202301322D0 (en) 2023-01-30 2023-03-15 Therakind Ltd Antiemetic pharmaceutical compositions for nasal delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634420A (en) * 1969-05-09 1972-01-11 American Cyanamid Co 3(morpholinomethyl)-2 3-dihydro-carbazol-4(1h)-ones
US3740404A (en) * 1969-05-09 1973-06-19 American Cyanamid Co Piperidinomethylenedihydrocarbazolones
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives

Also Published As

Publication number Publication date
BE901576A (fr) 1985-07-25
DK169521B1 (da) 1994-11-21
DE3502508C2 (it) 1990-05-03
HK33189A (en) 1989-04-28
KR850005439A (ko) 1985-08-26
AU579132B2 (en) 1988-11-17
ES8708224A1 (es) 1987-10-01
NO164025B (no) 1990-05-14
CY1479A (en) 1989-07-21
FI84349C (fi) 1991-11-25
ES539852A0 (es) 1986-07-16
DK35785A (da) 1985-07-26
HUT37784A (en) 1986-02-28
PT79890A (en) 1985-02-01
DE3502508A1 (de) 1985-08-14
ATA20485A (de) 1990-08-15
GB2153821A (en) 1985-08-29
FI850323A0 (fi) 1985-01-25
GB8501889D0 (en) 1985-02-27
GR850219B (it) 1985-05-23
ES548430A0 (es) 1987-10-01
ES8609309A1 (es) 1986-07-16
NL940009I1 (nl) 1994-07-18
NL8500202A (nl) 1985-08-16
SK277923B6 (en) 1995-08-09
NL190373B (nl) 1993-09-01
GB2153821B (en) 1988-01-20
IE850187L (en) 1985-07-25
IE57809B1 (en) 1993-04-21
IT1182150B (it) 1987-09-30
DK35785D0 (da) 1985-01-25
CH664152A5 (fr) 1988-02-15
NZ210940A (en) 1989-08-29
PH22672A (en) 1988-11-14
NL940009I2 (nl) 1999-05-03
FR2561244B1 (fr) 1988-03-04
DE19375046I2 (de) 2002-10-10
SG7089G (en) 1989-06-09
LU85743A1 (fr) 1986-08-04
FI84349B (fi) 1991-08-15
SE460359B (sv) 1989-10-02
SE8500368L (sv) 1985-07-26
LU88268I2 (it) 1994-02-03
NO850300L (no) 1985-07-26
NO1994022I1 (no) 1994-11-09
IL74165A (en) 1988-11-15
CZ404391A3 (en) 1993-04-14
NO164025C (no) 1990-08-22
ES556101A0 (es) 1987-12-16
AT392276B (de) 1991-02-25
FR2561244A1 (fr) 1985-09-20
ES8801247A1 (es) 1987-12-16
KR920003064B1 (ko) 1992-04-13
SE8500368D0 (sv) 1985-01-25
CA1252793A (en) 1989-04-18
AU3809785A (en) 1985-08-01
SK404391A3 (en) 1995-08-09
HU193592B (en) 1987-11-30
PT79890B (en) 1987-02-03
NL190373C (nl) 1994-02-01
FI850323L (fi) 1985-07-26

Similar Documents

Publication Publication Date Title
IT8547600A0 (it) Li contengono composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmacuetiche che
IT8348422A0 (it) Composti eterociclici, procedimento per prpararli e composizioni farmaceutiche che li contengono
IT8548551A0 (it) Antiparassitarie che li contengono composti antibiotici, composizioni e procedimento per prepararli ed applicarli
IT8248157A0 (it) Composti aril-ciclobutil-amminici sostituiti, procedimenti per prepararli, composti intermedi e composizioni farmaceutiche che li contengono
IT8149680A0 (it) Composti carbostirilici composizioni che li contengono e procedimenti per prepararli
DK552685A (da) Heterocycliske forbindelser
DK5884D0 (da) Antibiotisk virksom forbindelse, fremgangsmade til fremstilling deraf og praeparat indeholdende forbindelsen
IT8323634A0 (it) Composizione per fotoriproduzioni.
DK162485A (da) Heterocykliske forbindelser
IT8149085A0 (it) Composti eterociclici indolici,procedimento per produrli e composizioni farmaceutiche che li contengono
IT8348155A0 (it) Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
IT8049163A0 (it) Fenossiammine eterocicliche sostituite procedimento per prepararle e composizioni farmaceutiche che le contengono
FI851351A7 (fi) Heterosyklisiä yhdisteitä.
IT8348653A0 (it) Sizione farmaceutica che li contiederivati eterociclici tiadiazolici, ne procedimento per prepararli e compo
IT8049684A0 (it) Composti di cefalosporina procedimento per prepararli e composizioni che li contengono
DK496885A (da) Heterocycliske forbindelser
IT8748207A0 (it) Composti eterociclici che agiscono su ricetori di 5-idrossitriptammina composizioni che li contengono eprocedimento per prepararli
IT8147904A0 (it) Composti di piperazina procedimento per prepararli e composizioni immu nopotenziatrici che li contengono
IT8322665A0 (it) Procedimento per preparare composizioni contenenti gammaglobulina.
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
IT8148901A0 (it) Composti amminosteroidi composizioni farmaceutiche che li contengono e procedimento per prepararli
ES546846A0 (es) Procedimiento de preparar compuestos amidicos farmacologica-mente activos
KR860004939A (ko) N-치환된 아실-락탐 화합물을 제조하는 방법
FI832241A7 (fi) Antihypertensiivisina aineina käyttökelpoiset substituoidut fenyylipiperatsiiniyhdisteet, ja menetelniiden valmistamiseksi.
KR860004940A (ko) N-치환된 아실-락탐 화합물을 제조하는 방법

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 221

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 221, 19920504; GLAXO GROUP LIMITED

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960129